WO2022253060A1 - Leadless pacemaker, delivery device, and system - Google Patents

Leadless pacemaker, delivery device, and system Download PDF

Info

Publication number
WO2022253060A1
WO2022253060A1 PCT/CN2022/094835 CN2022094835W WO2022253060A1 WO 2022253060 A1 WO2022253060 A1 WO 2022253060A1 CN 2022094835 W CN2022094835 W CN 2022094835W WO 2022253060 A1 WO2022253060 A1 WO 2022253060A1
Authority
WO
WIPO (PCT)
Prior art keywords
unit
pacemaker
leadless pacemaker
housing
leadless
Prior art date
Application number
PCT/CN2022/094835
Other languages
French (fr)
Chinese (zh)
Inventor
成诗伟
邱丰伟
Original Assignee
创领心律管理医疗器械(上海)有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 创领心律管理医疗器械(上海)有限公司 filed Critical 创领心律管理医疗器械(上海)有限公司
Publication of WO2022253060A1 publication Critical patent/WO2022253060A1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/37211Means for communicating with stimulators
    • A61N1/37217Means for communicating with stimulators characterised by the communication link, e.g. acoustic or tactile
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings
    • A61N1/37512Pacemakers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/372Arrangements in connection with the implantation of stimulators
    • A61N1/375Constructional arrangements, e.g. casings
    • A61N1/3758Packaging of the components within the casing

Definitions

  • the invention relates to the technical field of medical devices, in particular to a leadless pacemaker, a delivery device and a system.
  • the leadless pacemaker implanted in the heart cavity has the advantages of less trauma, no influence on the appearance, and avoiding complications related to electrode leads, and has been more and more popular. more and more widely used.
  • patients with implanted cardiac leadless pacemakers need to go to the hospital for follow-up visits regularly, and exchange data with the implantable cardiac leadless pacemaker through specific equipment provided by the manufacturer.
  • the parameters of the leadless pacemaker can be adjusted to allow the leadless pacemaker to adapt to changes in the patient's physiology.
  • Traditional implantable pacemakers usually use a near-field coupling communication method for data interaction, and this communication method usually has a low carrier frequency, low data transmission rate, and short communication distance.
  • this near-field coupling method is difficult to ensure the accuracy of signal transmission. sex.
  • the leadless pacemaker is implanted in the patient's heart cavity, compared with the traditional lead pacemaker, the distance from the human body surface is longer, and the traditional near-field coupling communication basically cannot meet the needs of leadless pacing. The need for communication between the controller and the external control device.
  • the external control device When communication is established, the external control device needs a specific connection device to be connected to the surface of the human body, which is very inconvenient to operate.
  • the structure of the existing leadless pacemaker shields radio frequency signals: In order to ensure the safety of the leadless pacemaker, all electronic components of the leadless pacemaker must be enclosed in a metal titanium shell; and the airtight metal shell The body has a strong attenuation and shielding effect on radio frequency signals, so that the receiving device in the leadless pacemaker cannot receive the radio frequency signal sent by the external controller, and the radio frequency signal sent by the sending device in the leadless pacemaker cannot Outgoing metal titanium case.
  • FIG. 1 is a schematic structural diagram of one of the leadless pacemakers in the prior art. It can be seen from FIG. 1 that this kind of leadless pacemaker includes a pacemaker main body 11 and a ring-shaped bracket 12. In order to enable the leadless pacemaker body to have a better fixing effect, the first pacemaker The main body 11 is laterally attached to the outer wall of the ring bracket 12 .
  • the object of the present invention is to provide a leadless pacemaker, a delivery device and a system for the above-mentioned defects in the prior art, which can realize the leadless pacemaker while meeting the sealing requirements of the leadless pacemaker for electronic devices. Remote data exchange between the pacemaker and the external control device.
  • a leadless pacemaker comprising a first casing, a second casing, a first unit arranged in the first casing, and a first unit arranged in the second casing A second unit in the body and a pacemaker body; the second unit is electrically connected to the pacemaker body and the first unit respectively;
  • the first unit is configured to receive control information from an in vitro control device
  • the second unit is configured to receive the control information and send the control information to the pacemaker body;
  • the pacemaker body is configured to control the operation of the leadless pacemaker according to the control information; and send the operation information of the leadless pacemaker to the second unit;
  • the second unit is further configured to send the operation information to the first unit, and the first unit is further configured to send the operation information to the in vitro control device;
  • the first casing is made of biocompatible non-metallic material; the second casing includes a closed casing made of biocompatible metal material.
  • a first signal transmission unit is further included, the first end of the first signal transmission unit is located in the first housing, and the second end of the first signal transmission unit is located in the second housing;
  • the first unit is connected to the first end of the first signal transmission unit, and the second unit is connected to the second end of the first signal transmission unit.
  • it also includes a second signal transmission unit electrically connected to the pacemaker body, the first end of the second signal transmission unit is located in the second casing, and the first end of the second signal transmission unit is the two ends are located outside the second housing;
  • the second signal transmission unit is configured to transmit the physiological information of the subject to the pacemaker body.
  • a third shell is also included, the third shell is made of biocompatible non-metallic material;
  • the second end of the second signal transmission unit outside the second housing extends into the third housing.
  • a fixing unit is further included, the first end of the fixing unit is fixed on the outer wall of the third housing, and the second end is used to be fixed on the receptor.
  • it also includes a battery unit electrically connected to the pacemaker body, the battery unit is arranged in the second casing, and the battery unit is used for powering the pacemaker body and/or the pacemaker body.
  • the second unit is powered.
  • the second signal transmission unit and the battery unit are respectively located at opposite ends of the pacemaker body.
  • the battery unit is located between the pacemaker body and the second unit, and the outer wall of the battery unit has a groove;
  • the signal line connecting the pacemaker body and the second unit is located in the groove.
  • the operating information includes physiological information of the recipient and implantation status information of the leadless pacemaker;
  • the pacemaker body is used to send the physiological information and the implantation status information to the second unit.
  • the running information also includes battery information
  • the pacemaker body also includes a battery performance detection module, the battery performance detection module is configured to monitor the operating state of the battery, obtain the battery information according to the operating state of the battery, and send the battery information to the Describe the second unit.
  • the present invention also provides a delivery device, which is used to deliver the leadless pacemaker as described in any one of the above;
  • the delivery device includes: a delivery handle assembly, a delivery rod assembly, and a head-end part matched with the first casing of the leadless pacemaker, and the head-end part is arranged at the distal end of the delivery rod assembly , the delivery handle assembly is arranged at the proximal end of the delivery rod assembly and connected to the head end part through the delivery rod assembly;
  • the delivery device is configured to advance the leadless pacemaker to a target location and, upon reaching the target location, to release the leadless pacemaker.
  • the present invention also provides a leadless pacing system, which includes the leadless pacemaker described in any one of the above and the above delivery device.
  • the present invention also provides a wireless communication system based on implantable medical electronic devices, the wireless communication system includes an implanted device in the body and an external control device;
  • the implanted device in the body includes the leadless pacemaker described in any one of the above, and the external control device includes a wireless communication unit, and the wireless communication unit is used to communicate with the first unit of the leadless pacemaker. communication connection.
  • the leadless pacemaker, delivery device and system provided by the present invention have the following beneficial effects:
  • the leadless pacemaker provided by the present invention includes a first housing, a second housing, a first unit disposed in the first housing, a second unit and a pacemaker body disposed in the second housing;
  • the second unit is electrically connected to the pacemaker body and the first unit respectively.
  • the first housing is made of a biocompatible non-metallic material;
  • the second housing includes a closed housing made of a biocompatible metallic material.
  • the leadless pacemaker provided by the present invention has the function of radio frequency communication, and the first unit is located in the first housing to ensure that the transmitted or received radio frequency signal will not be attenuated and shielded by the second housing, thus realizing the leadless pacemaker Perform remote data interaction with the external control device; further, the second unit and the pacemaker body are located in the second housing, which can prevent the second unit and the pacemaker body from being affected by implantation. Physiological impact and erosion of the body, and at the same time, damage to the organ tissue of the implanted recipient by the second unit and the pacemaker body is reduced. Therefore, the leadless pacemaker provided by the present invention has the advantages of high data transmission rate and long communication distance, and can improve the convenience of follow-up visits after the implantation of the leadless pacemaker.
  • FIG. 1 is a schematic structural view of one of the leadless pacemakers in the prior art
  • Fig. 2 is a schematic structural diagram of a leadless pacemaker provided by an embodiment of the present invention.
  • Fig. 3 is one of the structural schematic diagrams of the second unit in Fig. 2;
  • Fig. 4 is one of the schematic diagrams of the battery unit in Fig. 2;
  • Fig. 5 is a structural schematic diagram of the pacemaker body in Fig. 2;
  • FIG. 6 is a schematic structural diagram of a transmission device provided by an embodiment of the present invention.
  • 410-data processing unit 420-intracavity electrocardiographic perception processing module, 430-myocardial contact evaluation module, 440-pacing voltage generation module, 450-battery performance detection module;
  • proximal and distal refer to the relative orientation, relative position, direction of elements or actions relative to each other from the perspective of a physician using the medical device, although “proximal” and “distal” are not limiting However, “proximal” generally refers to the end of the medical device that is closest to the physician during normal operation, and “distal” generally refers to the end that enters the patient first.
  • the inventors of the present invention have finally found through continuous in-depth research and a lot of practice that by improving the structure of the existing leadless pacemakers, the described Leadless pacemakers have radiofrequency capabilities.
  • the present invention provides a leadless pacemaker, a delivery device and a system.
  • the leadless pacemaker includes a first housing, a second housing, a first unit disposed in the first housing, and The second unit and the pacemaker body are arranged in the second casing; the second unit is electrically connected with the pacemaker body and the first unit.
  • the leadless pacemaker proposed by the present invention has the advantages of high data transmission rate and long communication distance, and can improve the convenience of follow-up visits after patients are implanted with the leadless pacemaker.
  • a leadless pacemaker proposed by the present invention will be described in detail below.
  • FIG. 2 is a schematic structural diagram of the leadless pacemaker provided by this embodiment. It can be seen from FIG. 2 that the leadless pacemaker provided by this embodiment includes a first housing 110, a second housing 120, a first unit 200 disposed in the first housing 110, and a first unit 200 disposed in the second The second unit 300 and the pacemaker body 400 inside the casing 120 ; the second unit 300 is electrically connected with the pacemaker body 400 and the first unit 200 .
  • the first unit 200 is configured to receive control information of an in vitro control device; the second unit 300 is configured to receive the control information and send the control information to the Pacemaker body 400; the pacemaker body 400 is configured to control the operation of the leadless pacemaker according to the control information; and send the operation information of the leadless pacemaker to the The second unit 300; the second unit 300 is also configured to send the operation information to the first unit 200, and the first unit 200 is also configured to send the operation information to the External control device.
  • the first casing 110 is made of biocompatible non-metallic material; the second casing 120 includes a closed casing made of biocompatible metal material.
  • the biocompatible non-metallic materials include but not limited to bioglass, bioceramics, biocement, and bioglass ceramics.
  • the first housing 110 can not only ensure that the first unit 200 remains insulated from the outside, but also, the biocompatible non-metallic material is easy to be sterilized at high temperature, and has good chemical stability in the human body, tissue Good compatibility and high compressive strength; further, the first housing 110 can avoid direct contact between the first unit 200 and the blood and/or organ tissue of the implanted recipient, avoiding the first A unit 200 is protected from impact and erosion by blood and/or organ tissue of the implanted recipient.
  • the first housing 110 can cooperate with an external delivery device (such as a delivery handle) to deliver the leadless pacemaker to a target position; the first unit 200 is set on the In the first casing 110 , under the condition of ensuring stable signal transmission, the overall volume of the lead pacemaker is not increased, and the available space can be effectively used.
  • the biocompatible metal materials include but are not limited to pure metals such as titanium, tantalum, niobium and zirconium, medical stainless steel, cobalt-based alloys, titanium-based alloys and other alloys. With such a configuration, the second casing 120 has good corrosion resistance, which can prevent the second unit 300 and the pacemaker body 400 from losing their functions due to external influences and prolong their service life.
  • the first unit 200 of the leadless pacemaker provided by the present invention includes, but is not limited to, an antenna capable of receiving and transmitting radio frequency signals.
  • the radio frequency signal will not be attenuated and shielded, and the remote data interaction between the leadless pacemaker and the external control device can be realized; further, the second unit 300 and the pacemaker body 400 are located in the second housing 120, the second housing 120 can prevent the second unit 300 and the pacemaker body 400 from being affected and eroded by the blood and/or organ tissue of the implanted recipient, and also reduce the second The damage of the unit 300 and the pacemaker body 400 to the organ tissue of the implanted recipient. Therefore, the leadless pacemaker provided by the present invention can prevent the radio frequency signal from being shielded and attenuated by the metal casing, and realize the radio frequency communication function of the leadless pacemaker.
  • the leadless pacemaker provided by the present invention has the advantages of high data transmission rate and long communication distance, and can improve the convenience of follow-up visits after the implantation of the leadless pacemaker.
  • FIG. 3 is a schematic structural diagram of the second unit. It can be seen from FIG. 3 that the second unit 300 includes a matching network module 310 , and a radio frequency signal receiving module 320 and a radio frequency signal sending module 330 electrically connected to the matching network module 310 .
  • the radio frequency signal receiving module 320 is configured to convert the control information from radio frequency signals into low frequency signals; the radio frequency signal sending module 330 is configured to convert the operating information from low frequency signals to RF signal.
  • the second unit 300 is electrically connected to the pacemaker body 400 and the first unit 200, including: the radio frequency signal receiving module 320 and the radio frequency signal sending module 330 are both connected to the pacemaker
  • the main body 400 is electrically connected; the matching network module 310 is electrically connected to the first unit 200 .
  • the matching network module 310 is used to make the electrical characteristics of the second unit 300 and the external control device consistent to form an RF matching network, so as to minimize the loss and distortion of radio signal transmission.
  • the same electrical characteristics are also called impedance matching, including that the internal resistance of the signal source (external control device) is equal in size and phase to the characteristic impedance of the connected transmission line, and/or the characteristic impedance of the transmission line is the same as the connected load (second unit) impedances are equal in magnitude and in phase.
  • the radio frequency signal receiving module 320 and the radio frequency signal sending module 330 are only exemplary descriptions of preferred embodiments, rather than limitations of the present invention. In other embodiments, the radio frequency signal receiving module 320
  • the RF signal transmitting module 330 may also be an integrated RF signal transmitting and receiving module, which is not limited in the present invention.
  • the leadless pacemaker provided in this embodiment further includes a first signal transmission unit 500, and the first signal transmission unit 500
  • One end of the first signal transmission unit 500 is located in the first housing 110
  • the other end of the first signal transmission unit 500 is located in the second housing 120 .
  • the first unit 200 is connected to one end of the first signal transmission unit 500
  • the matching network module 310 is connected to the other end of the first signal transmission unit 500 .
  • the first signal transmission unit 500 can ensure smooth electrical signals between the first unit 200 and the second unit 300, specifically, the first signal transmission unit 500 is a feed-through element.
  • the leadless pacemaker provided by the present invention further includes a second signal transmission unit 600 electrically connected to the pacemaker body 400, and the second signal transmission unit One end of the 600 is located inside the second housing 120 , and the other end of the second signal transmission unit 600 is located outside the second housing 120 .
  • the second signal transmission unit 600 is configured to transmit the physiological information of the subject to the pacemaker body 400 .
  • the external circuits include but not limited to physiological parameter sensors, pacemaker pacing sensor) can enable the pacemaker body inside the second housing 120 to transmit electrical signals with external circuits, so that the pacemaker body 400 can sense and/or pace the implanted
  • the receiver, specifically, the second signal transmission unit 600 is a feedthrough element.
  • a third housing 130 is further included, and the third housing 130 is made of biocompatible non-metallic material.
  • the other end of the second signal transmission unit 600 outside the second housing 120 extends into the third housing 130 .
  • the third housing 130 can not only protect the second signal transmission unit 600, so that the leadless pacemaker can meet the requirements of increased contact tightness with implanted recipients (such as myocardium); and
  • the third housing 130 can also serve as the base of the fixing unit 700 .
  • the biocompatible non-metallic materials include but are not limited to bioglass, bioceramics, biocement, and bioglass ceramics, etc., which will not be repeated here.
  • the first casing 110 , the second casing 120 and the third casing 130 centerlines are on the same straight line.
  • the connection between the first housing 110 and the second housing 120 is a hermetic connection, that is, the first signal transmission unit 500 is completely enclosed by the first housing 110 and the second housing.
  • Body 120 is airtightly covered; similarly, the connection between the second housing 120 and the third housing 130 is also airtight connection, that is, the second signal transmission unit 600 is completely covered by the second housing 120 and the third casing 130 are airtightly covered.
  • first casing 110, the second casing 120 and the third casing 130 are all cylinders with the same outer diameter, and are configured in such a way that the shape of the leadless pacemaker is similar to a capsule
  • the structure not only facilitates the transportation and implantation of the transmission device, but also greatly reduces its external size, reduces the contact area with the implanted receptor, and can accurately approach the lesion, thereby improving the therapeutic effect.
  • the leadless pacemaker further includes a fixing unit 700, one end of the fixing unit 700 is fixed on the outer wall of the third housing 130, And the other end of the fixing unit 700 is used to be fixed on the receptor.
  • the fixing unit 700 can fix the leadless pacemaker to the implant recipient (such as the myocardium), so that the front end of the leadless pacemaker can be in close contact with the myocardium.
  • the third housing 130 serves as the base of the fixing unit 700, which is more convenient for tightly fixing the fixing unit 700 and the leadless pacemaker together.
  • the leadless pacemaker further includes a battery unit 800 electrically connected to the pacemaker body 400 , and the battery unit 800 is arranged in the second casing 120 Inside, the battery unit 800 is used for powering the pacemaker body 400 and/or the second unit 300 . Further, the second signal transmission unit 600 and the battery unit 800 are respectively located at opposite ends of the pacemaker body 400 .
  • a battery unit 800 electrically connected to the pacemaker body 400
  • the battery unit 800 is arranged in the second casing 120
  • the battery unit 800 is used for powering the pacemaker body 400 and/or the second unit 300 .
  • the second signal transmission unit 600 and the battery unit 800 are respectively located at opposite ends of the pacemaker body 400 .
  • FIG. 4 is a schematic diagram of one battery unit of the leadless pacemaker provided by the present invention. 2 and 4, it can be seen that the battery unit 800 is located between the leadless pacemaker body 400 and the second unit 300, and the outer wall of the battery unit 800 has a groove; The signal lines of the pacemaker body 400 and the second unit 300 are located in the groove. Different from the traditional cylindrical battery, the battery unit 800 of this embodiment has a groove. Such configuration further enables the signal line between the second unit 300 and the pacemaker body 400 to make full use of the space, not only The wiring is reasonable and easy to implement, and the space is rationally utilized to reduce the volume of the leadless pacemaker.
  • the leadless pacemaker is a cardiac leadless pacemaker
  • the implanted recipient includes a cardiac chamber of a patient.
  • FIG. 5 is a structural schematic diagram of the pacemaker body of the leadless pacemaker. It can be seen from FIG. 5 that the pacemaker body 400 includes: a data processing unit 410, an intracavity electrocardiographic sensing processing module 420 electrically connected to the data processing unit 410, a myocardial contact evaluation module 430, and a pacing voltage generating module. Module 440.
  • the intracavity electrocardiographic sensing processing module 420 is configured to detect the patient's electrocardiographic activity, and obtain the patient's physiological information according to the patient's electrocardiographic activity information.
  • the myocardial contact evaluation module 430 is configured to monitor the contact state between the leadless pacemaker and the myocardium, and obtain information about the implantation state of the leadless pacemaker.
  • the data processing unit 410 is configured to generate pacing control according to the control information, the physiological information and the implantation status information.
  • the pacing voltage generation module 440 is configured to generate a pulse stimulation voltage according to the pacing control; the pulse stimulation voltage is sent out of the second casing 120 through the second signal transmission unit 600 .
  • the second unit 300 is electrically connected to the pacemaker body 400 , including: the data processing unit 410 of the pacemaker body 400 is connected to the second unit 300 . Further, the pacemaker body 400 is electrically connected to the second signal transmission unit 600, including the intracavity electrocardiographic sensing processing module 420 and the pacing voltage generation module 440 and the second signal transmission unit 600 electrical connection.
  • the operation information includes physiological information of the recipient and implantation status information of the leadless pacemaker.
  • the pacemaker body 400 is configured to send the physiological information and the implantation status information to the second unit 300 .
  • the second unit 300 sends the physiological information and the implantation status information to an in vitro control device via the first unit 200 .
  • the external control device can be informed of the real-time working state of the leadless pacemaker and the physiological state of the patient in time, so as to adjust the control information so that the leadless pacemaker can adapt to the physiological changes of the patient, Safer and more effective pacing stimulation.
  • the running information also includes battery information.
  • the pacemaker body also includes a battery performance detection module 450, the battery performance detection module 450 is configured to monitor the battery operating state, obtain the battery information according to the battery operating state, and send the battery information to to the pacemaker body (in this embodiment, the data processing unit 410). With such a configuration, an alarm message will be issued before the battery power is exhausted, so as to deal with it in time.
  • the battery information also includes battery life, health status, etc., which will not be repeated here.
  • the pacemaker body 400 is further configured to send the battery information to the second unit 300 . Further, the second unit 300 sends the battery information to the external control device via the first unit 200 . With such a configuration, the external control device can be informed of the battery health status of the leadless pacemaker in time, so that corresponding countermeasures can be taken in time, so that the leadless pacemaker can operate normally.
  • the first unit 200 is located in the first casing 110 to ensure that the transmitted or received radio frequency signal will not be attenuated and shielded by the second casing 120, realizing the leadless pacemaker.
  • the pacemaker body 400 is protected from the physiological impact and erosion of the implant recipient, and at the same time reduces the damage of the second unit 300 and the pacemaker body 400 to the organ tissue of the implant recipient. Therefore, the leadless pacemaker provided by the present invention has the advantages of high data transmission rate and long communication distance, and can improve the convenience of follow-up visits after the implantation of the leadless pacemaker.
  • FIG. 6 is a schematic structural diagram of a transmission device provided by an embodiment of the present invention. It can be seen from FIG. 6 that the delivery device includes: a delivery handle assembly 930, a delivery rod assembly 920, and a head end part 910 that cooperates with the first housing 110 of the leadless pacemaker.
  • the component 910 is arranged at the far end of the delivery rod assembly 920, and the delivery handle assembly 930 is arranged at the proximal end of the delivery rod assembly 920 and connected to the head end part 910 through the delivery rod assembly 920;
  • the delivery device is configured to advance the leadless pacemaker to a target location, and upon reaching the target location, release the leadless pacemaker.
  • the leadless pacemaker provided by the present invention can be implanted into the patient's right ventricle via the femoral vein using the delivery device shown in FIG. 6 .
  • the head end part 910 of the delivery device is connected with the first casing 110 of the leadless pacemaker, and then the leadless pacemaker is delivered into the body.
  • any delivery device in the prior art that can play the above role can deliver the leadless pacemaker proposed by the present invention, and the present invention does not make any limitation thereto; further, the leadless pacemaker proposed by the present invention
  • the device is not limited to be transported by the transport device, but can also be installed in other ways, which is not limited in the present invention.
  • Another embodiment of the present invention also provides a leadless pacing system, which includes the leadless pacemaker described in any one of the above and the above delivery device.
  • the leadless pacing system provided by the present invention belongs to the same inventive concept as the leadless pacemaker provided by the present invention, it has at least the same beneficial effect, which will not be repeated here.
  • the wireless communication system includes an internal implant device and an external control device; wherein the internal implant device includes any of the above-mentioned
  • the external control device includes a wireless communication unit, and the wireless communication unit is used for communicating with the first unit of the leadless pacemaker.
  • the leadless pacemaker proposed by the present invention has the first unit 200 disposed in the first housing 110 , the second unit 300 and the pacemaker body 400 disposed in the second housing 120 ;
  • the second unit 300 is electrically connected to the pacemaker body 400 and the first unit 200 .
  • the wireless communication system with the leadless pacemaker proposed by the present invention can overcome the low carrier frequency, low data transmission rate, short communication distance and poor communication quality of human body communication in the prior art. It can ensure that the transmitted or received radio frequency signal will not be attenuated and shielded, thus realizing the long-distance data interaction between the leadless pacemaker and the external control device, and improving the follow-up safety of patients after implantation of the leadless pacemaker Convenience.
  • first and second are used for descriptive purposes only, and cannot be interpreted as indicating or implying relative importance or implicitly specifying the quantity of indicated technical features.
  • the features defined as “first” and “second” may explicitly or implicitly include at least one of these features.
  • “plurality” means at least two, such as two, three, etc., unless otherwise specifically defined.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Radiology & Medical Imaging (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Physics & Mathematics (AREA)
  • Acoustics & Sound (AREA)
  • Biophysics (AREA)
  • Electrotherapy Devices (AREA)

Abstract

A leadless pacemaker, a delivery device, and a system. The leadless pacemaker comprises a first housing (110), a second housing (120), a first unit (200) arranged in the first housing (110), and a second unit (300) and a pacemaker body (400) which are arranged in the second housing (120), wherein the second unit (300) is electrically connected to the pacemaker body (400) and the first unit (200); the first housing (110) is made of a biocompatible non-metallic material; and the second housing (120) comprises an enclosed housing made of a biocompatible metallic material. The leadless pacemaker, the delivery device and the system can ensure that the transmitted or received radio frequency signals will not be attenuated and shielded, can realize long-distance data interaction between the leadless pacemaker and an external control device, and can improve the convenience of follow-up after the patient has the leadless pacemaker implanted.

Description

无导线起搏器、输送装置及系统Leadless pacemakers, delivery devices and systems 技术领域technical field
本发明涉及医疗器械技术领域,尤其涉及一种无导线起搏器、输送装置及系统。The invention relates to the technical field of medical devices, in particular to a leadless pacemaker, a delivery device and a system.
背景技术Background technique
和传统的植入式心脏无导线起搏器植入皮下不同,植入心腔的无导线起搏器因其具有创伤小,不影响美观,以及避免和电极导线相关并发症的优势,得到越来越广泛的应用。Different from the traditional implantable cardiac leadless pacemaker implanted subcutaneously, the leadless pacemaker implanted in the heart cavity has the advantages of less trauma, no influence on the appearance, and avoiding complications related to electrode leads, and has been more and more popular. more and more widely used.
为了更加安全有效地进行起搏刺激,装有植入心脏无导线起搏器的患者需要定期去医院进行复诊,通过厂商提供的特定设备和植入式心脏无导线起搏器进行数据交互,医生可调节无导线起搏器的参数使得无导线起搏器适应患者的生理的变化。In order to perform pacing stimulation more safely and effectively, patients with implanted cardiac leadless pacemakers need to go to the hospital for follow-up visits regularly, and exchange data with the implantable cardiac leadless pacemaker through specific equipment provided by the manufacturer. The parameters of the leadless pacemaker can be adjusted to allow the leadless pacemaker to adapt to changes in the patient's physiology.
传统的植入式起搏器通常采用近场耦合的通信方式进行数据交互,而这种通信方式通常载波频率低,数据传输率低,通信距离短。然而,由于植入心腔的无导线起搏器和体外控制装置间的数据交互通常是无创的,即不是通过有线的方式进行连接,这种近场耦合的方式很难保证信号传输时的准确性。而且,由于无导线起搏器植入在病人的心腔内,和传统的有导线起搏器相比,距离人体体表的距离更长,传统的近场耦合通信基本无法满足无导线起搏器和体外控制装置通信的需求。Traditional implantable pacemakers usually use a near-field coupling communication method for data interaction, and this communication method usually has a low carrier frequency, low data transmission rate, and short communication distance. However, since the data interaction between the leadless pacemaker implanted in the heart chamber and the external control device is usually non-invasive, that is, it is not connected through a wired method, this near-field coupling method is difficult to ensure the accuracy of signal transmission. sex. Moreover, since the leadless pacemaker is implanted in the patient's heart cavity, compared with the traditional lead pacemaker, the distance from the human body surface is longer, and the traditional near-field coupling communication basically cannot meet the needs of leadless pacing. The need for communication between the controller and the external control device.
为了保证无导线起搏器和体外控制装置间的数据正常交互,现有技术中通常采用人体通信的方式,即以人的身体作为传输介质,进行信号的传输。但是该种通信方式却存在如下缺陷:In order to ensure the normal data interaction between the leadless pacemaker and the external control device, in the prior art, human body communication is usually used, that is, the human body is used as a transmission medium for signal transmission. However, this communication method has the following defects:
1、容易受到噪声的影响,通信质量易难以保证。1. It is easily affected by noise, and the communication quality is difficult to guarantee.
2、在建立通信的时候,体外控制装置需要特定的连接装置连接到人体体表,操作很不方便。2. When communication is established, the external control device needs a specific connection device to be connected to the surface of the human body, which is very inconvenient to operate.
也曾有本领域的技术人员试图将具有高数据传输率,通信距离远的射频通信技术应用到无导线起搏器,然而,目前还没有公开资料记载相关的成功 案例。这是因为,在无导线起搏器中集成射频通信功能几乎是不可能的。原因如下:There have also been attempts by those skilled in the art to apply radio frequency communication technology with high data transmission rate and long communication distance to leadless pacemakers. However, there are no relevant successful cases recorded in public information. This is because integrating RF communication into a leadless pacemaker is nearly impossible. The reasons are as follows:
1、现有的无导线起搏器的结构屏蔽射频信号:为了保证无导线起搏器的安全性,无导线起搏器的所有电子部件均需被封闭在金属钛壳体内;而密闭金属壳体对于射频信号具有很强的衰减屏蔽作用,由此导致无导线起搏器内的接收装置无法接收到体外控制器发出的射频信号,无导线起搏器内的发送装置发送的射频信号也无法传出金属钛壳。1. The structure of the existing leadless pacemaker shields radio frequency signals: In order to ensure the safety of the leadless pacemaker, all electronic components of the leadless pacemaker must be enclosed in a metal titanium shell; and the airtight metal shell The body has a strong attenuation and shielding effect on radio frequency signals, so that the receiving device in the leadless pacemaker cannot receive the radio frequency signal sent by the external controller, and the radio frequency signal sent by the sending device in the leadless pacemaker cannot Outgoing metal titanium case.
2、改进现有的无导线起搏器结构难度较大:参见图1,图1为现有技术的其中一种无导线起搏器的结构示意图。从图1中可以看出,该种无导线起搏器包括起博器主体11和环状支架12,为了能够使得无导线起搏器本体,具有更好的固定效果,所述第一起博器主体11横向紧贴在环状支架12的外壁。2. It is very difficult to improve the structure of the existing leadless pacemaker: see FIG. 1 , which is a schematic structural diagram of one of the leadless pacemakers in the prior art. It can be seen from FIG. 1 that this kind of leadless pacemaker includes a pacemaker main body 11 and a ring-shaped bracket 12. In order to enable the leadless pacemaker body to have a better fixing effect, the first pacemaker The main body 11 is laterally attached to the outer wall of the ring bracket 12 .
因此,如何提供一种无导线起搏器,日益成为本领域技术人员亟待解决的技术问题之一。Therefore, how to provide a leadless pacemaker has increasingly become one of the technical problems to be solved urgently by those skilled in the art.
需要说明的是,公开于该发明背景技术部分的信息仅仅旨在加深对本发明一般背景技术的理解,而不应当被视为承认或以任何形式暗示该信息构成已为本领域技术人员所公知的现有技术。It should be noted that the information disclosed in the background technology section of the invention is only intended to deepen the understanding of the general background technology of the invention, and should not be regarded as an acknowledgment or in any form to imply that the information constitutes information already known to those skilled in the art. current technology.
发明内容Contents of the invention
本发明的目的在于,针对现有技术中存在的上述缺陷,提供一种无导线起搏器、输送装置及系统,在满足无导线起搏器对电子器件的密闭要求的同时,以实现无导线起搏器与体外控制装置之间进行远距离的数据交互。The object of the present invention is to provide a leadless pacemaker, a delivery device and a system for the above-mentioned defects in the prior art, which can realize the leadless pacemaker while meeting the sealing requirements of the leadless pacemaker for electronic devices. Remote data exchange between the pacemaker and the external control device.
为实现上述目的,本发明通过以下技术方案予以实现:一种无导线起搏器,包括第一壳体、第二壳体、设置在第一壳体内的第一单元、以及设置在第二壳体内的第二单元和起搏器本体;所述第二单元分别与所述起搏器本体和所述第一单元电连接;In order to achieve the above object, the present invention is achieved through the following technical solutions: a leadless pacemaker, comprising a first casing, a second casing, a first unit arranged in the first casing, and a first unit arranged in the second casing A second unit in the body and a pacemaker body; the second unit is electrically connected to the pacemaker body and the first unit respectively;
所述第一单元,其被配置为接收体外控制装置的控制信息;The first unit is configured to receive control information from an in vitro control device;
所述第二单元,其被配置为接收所述控制信息,并用于将所述控制信息发送至所述起搏器本体;The second unit is configured to receive the control information and send the control information to the pacemaker body;
所述起搏器本体,其被配置为根据所述控制信息,控制所述无导线起搏器的运行;并将所述无导线起搏器的运行信息发送至所述第二单元;The pacemaker body is configured to control the operation of the leadless pacemaker according to the control information; and send the operation information of the leadless pacemaker to the second unit;
所述第二单元,还被配置为将所述运行信息发送至所述第一单元,所述第一单元还被配置为将所述运行信息发送至所述体外控制装置;The second unit is further configured to send the operation information to the first unit, and the first unit is further configured to send the operation information to the in vitro control device;
其中,所述第一壳体由生物可兼容非金属材料制成;所述第二壳体包括由生物可兼容金属材料制成的封闭壳体。Wherein, the first casing is made of biocompatible non-metallic material; the second casing includes a closed casing made of biocompatible metal material.
可选地,还包括第一信号传输单元,所述第一信号传输单元的第一端位于所述第一壳体内,所述第一信号传输单元的第二端位于所述第二壳体内;Optionally, a first signal transmission unit is further included, the first end of the first signal transmission unit is located in the first housing, and the second end of the first signal transmission unit is located in the second housing;
所述第一单元连接所述第一信号传输单元的第一端,所述第二单元连接所述第一信号传输单元的第二端。The first unit is connected to the first end of the first signal transmission unit, and the second unit is connected to the second end of the first signal transmission unit.
可选地,还包括与所述起搏器本体电连接的第二信号传输单元,所述第二信号传输单元的第一端位于所述第二壳体内,所述第二信号传输单元的第二端位于所述第二壳体外;Optionally, it also includes a second signal transmission unit electrically connected to the pacemaker body, the first end of the second signal transmission unit is located in the second casing, and the first end of the second signal transmission unit is the two ends are located outside the second housing;
所述第二信号传输单元,其被配置为将受体的生理信息发送至所述起搏器本体。The second signal transmission unit is configured to transmit the physiological information of the subject to the pacemaker body.
可选地,还包括第三壳体,所述第三壳体由生物可兼容非金属材料制成;Optionally, a third shell is also included, the third shell is made of biocompatible non-metallic material;
所述第二信号传输单元的位于所述第二壳体外的第二端延伸入所述第三壳体内。The second end of the second signal transmission unit outside the second housing extends into the third housing.
可选地,还包括一固定单元,所述固定单元的第一端固定在所述第三壳体的外壁,并且第二端用于固定在所述受体上。Optionally, a fixing unit is further included, the first end of the fixing unit is fixed on the outer wall of the third housing, and the second end is used to be fixed on the receptor.
可选地,还包括与所述起搏器本体电连接的电池单元,所述电池单元设置在所述第二壳体内,所述电池单元用于为所述起搏器本体和/或所述第二单元供电。Optionally, it also includes a battery unit electrically connected to the pacemaker body, the battery unit is arranged in the second casing, and the battery unit is used for powering the pacemaker body and/or the pacemaker body. The second unit is powered.
可选地,所述第二信号传输单元和所述电池单元分别位于所述起搏器本体相对的两端。Optionally, the second signal transmission unit and the battery unit are respectively located at opposite ends of the pacemaker body.
可选地,所述电池单元位于所述起搏器本体和所述第二单元之间,且所述电池单元的外壁具有一凹槽;Optionally, the battery unit is located between the pacemaker body and the second unit, and the outer wall of the battery unit has a groove;
连接所述起搏器本体和所述第二单元的信号线位于所述凹槽内。The signal line connecting the pacemaker body and the second unit is located in the groove.
可选地,所述运行信息包括受体的生理信息和所述无导线起搏器的植入状态信息;Optionally, the operating information includes physiological information of the recipient and implantation status information of the leadless pacemaker;
所述起搏器本体用于,将所述生理信息和所述植入状态信息发送至所述第二单元。The pacemaker body is used to send the physiological information and the implantation status information to the second unit.
可选地,所述运行信息还包括电池信息;Optionally, the running information also includes battery information;
所述起搏器本体还包括电池性能检测模块,所述电池性能检测模块,被配置为监测电池运行状态,并根据所述电池运行状态获取所述电池信息,并将所述电池信息发送至所述第二单元。The pacemaker body also includes a battery performance detection module, the battery performance detection module is configured to monitor the operating state of the battery, obtain the battery information according to the operating state of the battery, and send the battery information to the Describe the second unit.
为实现上述目的,本发明还提供了一种输送装置,所述输送装置用于输送如上述任一项所述的无导线起搏器;To achieve the above object, the present invention also provides a delivery device, which is used to deliver the leadless pacemaker as described in any one of the above;
所述输送装置包括:输送手柄组件、输送杆组件和与所述无导线起搏器的所述第一壳体配合的头端部件,所述头端部件设置在所述输送杆组件的远端,所述输送手柄组件设置在所述输送杆组件的近端并经所述输送杆组件与所述头端部件相连;The delivery device includes: a delivery handle assembly, a delivery rod assembly, and a head-end part matched with the first casing of the leadless pacemaker, and the head-end part is arranged at the distal end of the delivery rod assembly , the delivery handle assembly is arranged at the proximal end of the delivery rod assembly and connected to the head end part through the delivery rod assembly;
所述输送装置被配置为将所述无导线起搏器推送至目标位置,并在到达所述目标位置后,释放所述无导线起搏器。The delivery device is configured to advance the leadless pacemaker to a target location and, upon reaching the target location, to release the leadless pacemaker.
为实现上述目的,本发明还提供了一种无导线起搏系统,其包括上述任一项所述的无导线起搏器以及上述的输送装置。To achieve the above object, the present invention also provides a leadless pacing system, which includes the leadless pacemaker described in any one of the above and the above delivery device.
为实现上述目的,本发明还提供了一种基于植入式医疗电子器件的无线通信系统,所述无线通信系统包括体内植入装置和体外控制装置;To achieve the above object, the present invention also provides a wireless communication system based on implantable medical electronic devices, the wireless communication system includes an implanted device in the body and an external control device;
其中,所述体内植入装置包括上述任一项所述的无导线起搏器,所述体外控制装置包括无线通信单元,该无线通信单元用于与所述无导线起搏器的第一单元通信连接。Wherein, the implanted device in the body includes the leadless pacemaker described in any one of the above, and the external control device includes a wireless communication unit, and the wireless communication unit is used to communicate with the first unit of the leadless pacemaker. communication connection.
与现有技术相比,本发明提供的无导线起搏器、输送装置及系统,具有如下有益效果:Compared with the prior art, the leadless pacemaker, delivery device and system provided by the present invention have the following beneficial effects:
本发明提供的无导线起搏器,包括第一壳体、第二壳体、设置在第一壳体内的第一单元、以及设置在第二壳体内的第二单元和起搏器本体;所述第二单元分别与所述起搏器本体和所述第一单元电连接。所述第一壳体由生物 可兼容非金属材料制成;所述第二壳体包括由生物可兼容金属材料制成的封闭壳体。如此配置,本发明提供的无导线起搏器具有射频通信功能,第一单元位于第一壳体内,保证发送或接收的射频信号不会被第二壳体衰减屏蔽,实现了无导线起搏器与体外控制装置之间进行远距离数据交互;进一步地,所述第二单元和起搏器本体位于所述第二壳体内,能够避免所述第二单元和起搏器本体免受植入受体生理影响和侵蚀,同时也降低了所述第二单元和起搏器本体对植入受体器官组织的损伤。由此,本发明提供的无导线起搏器具有高数据传输率,通信距离远的优点,能够提高患者植入无导线起搏器后随访的便捷性。The leadless pacemaker provided by the present invention includes a first housing, a second housing, a first unit disposed in the first housing, a second unit and a pacemaker body disposed in the second housing; The second unit is electrically connected to the pacemaker body and the first unit respectively. The first housing is made of a biocompatible non-metallic material; the second housing includes a closed housing made of a biocompatible metallic material. With such a configuration, the leadless pacemaker provided by the present invention has the function of radio frequency communication, and the first unit is located in the first housing to ensure that the transmitted or received radio frequency signal will not be attenuated and shielded by the second housing, thus realizing the leadless pacemaker Perform remote data interaction with the external control device; further, the second unit and the pacemaker body are located in the second housing, which can prevent the second unit and the pacemaker body from being affected by implantation. Physiological impact and erosion of the body, and at the same time, damage to the organ tissue of the implanted recipient by the second unit and the pacemaker body is reduced. Therefore, the leadless pacemaker provided by the present invention has the advantages of high data transmission rate and long communication distance, and can improve the convenience of follow-up visits after the implantation of the leadless pacemaker.
附图说明Description of drawings
图1为现有技术的其中一种无导线起搏器的结构示意图;FIG. 1 is a schematic structural view of one of the leadless pacemakers in the prior art;
图2为本发明一实施例提供的无导线起搏器的结构示意图;Fig. 2 is a schematic structural diagram of a leadless pacemaker provided by an embodiment of the present invention;
图3为图2中的第二单元的其中一种结构示意图;Fig. 3 is one of the structural schematic diagrams of the second unit in Fig. 2;
图4为图2中的电池单元的其中一种示意图;Fig. 4 is one of the schematic diagrams of the battery unit in Fig. 2;
图5为图2中的起搏器本体的其中一种结构示意图;Fig. 5 is a structural schematic diagram of the pacemaker body in Fig. 2;
图6为本发明一实施例提供的传输装置结构示意图;FIG. 6 is a schematic structural diagram of a transmission device provided by an embodiment of the present invention;
其中,附图标记说明如下:Wherein, the reference signs are explained as follows:
11-起博器主体、12-环状支架;11-pacemaker main body, 12-ring bracket;
110-第一壳体、120-第二壳体、130-第三壳体、200-第一单元、300-第二单元、400-起搏器本体、500-第一信号传输单元、600-第二信号传输单元、700-固定单元、800-电池单元;110-first housing, 120-second housing, 130-third housing, 200-first unit, 300-second unit, 400-pacemaker body, 500-first signal transmission unit, 600- The second signal transmission unit, 700-fixed unit, 800-battery unit;
310-匹配网络模块、320-射频信号接收模块、330-射频信号发送模块;310-matching network module, 320-radio frequency signal receiving module, 330-radio frequency signal sending module;
410-数据处理单元、420-腔内心电感知处理模块、430-心肌接触评估模块、440-起搏电压产生模块、450-电池性能检测模块;410-data processing unit, 420-intracavity electrocardiographic perception processing module, 430-myocardial contact evaluation module, 440-pacing voltage generation module, 450-battery performance detection module;
910-头端部件、920-输送杆组件、930-输送手柄组件。910-head end part, 920-delivery rod assembly, 930-delivery handle assembly.
具体实施方式Detailed ways
为使本发明的目的、优点和特征更加清楚,以下结合附图对本发明提出的无导线起搏器、输送装置及系统作进一步详细说明。需说明的是,附图均采用非常简化的形式且均使用非精准的比例,仅用以方便、明晰地辅助说明本发明实施例的目的。应当了解,说明书附图并不一定按比例地显示本发明的具体结构,并且在说明书附图中用于说明本发明某些原理的图示性特征也会采取略微简化的画法。本文所公开的本发明的具体设计特征包括例如具体尺寸、方向、位置和外形将部分地由具体所要应用和使用的环境来确定。以及,在以下说明的实施方式中,有时在不同的附图之间共同使用同一附图标记来表示相同部分或具有相同功能的部分,而省略其重复说明。在本说明书中,使用相似的标号和字母表示类似项,因此,一旦某一项在一个附图中被定义,则在随后的附图中不需要对其进行进一步讨论。In order to make the purpose, advantages and features of the present invention clearer, the leadless pacemaker, delivery device and system proposed by the present invention will be further described in detail below with reference to the accompanying drawings. It should be noted that all the drawings are in a very simplified form and use imprecise scales, and are only used to facilitate and clearly assist the purpose of illustrating the embodiments of the present invention. It should be understood that the drawings in the specification do not necessarily show the specific structure of the invention to scale, and that the illustrative features used to illustrate some principles of the invention in the drawings in the specification are also drawn in a somewhat simplified manner. The specific design features of the invention disclosed herein, including, for example, specific dimensions, orientations, locations and shapes will be determined in part by the particular intended application and use environment. Also, in the embodiments described below, the same reference numerals may be used in common between different drawings to denote the same parts or parts having the same functions, and repeated descriptions thereof will be omitted. In this specification, similar reference numerals and letters are used to refer to similar items, therefore, once an item is defined in one figure, it does not require further discussion in subsequent figures.
术语“近端”和“远端”是从使用该医疗器械的医生角度来看相对于彼此的元件或动作的相对方位、相对位置、方向,尽管“近端”和“远端”并非是限制性的,但是“近端”通常指该医疗设备在正常操作过程中靠近医生的一端,而“远端”通常是指首先进入患者体内的一端。The terms "proximal" and "distal" refer to the relative orientation, relative position, direction of elements or actions relative to each other from the perspective of a physician using the medical device, although "proximal" and "distal" are not limiting However, "proximal" generally refers to the end of the medical device that is closest to the physician during normal operation, and "distal" generally refers to the end that enters the patient first.
由于长期致力于无线起搏器的研究和开发工作,本发明的发明人经过不断深入的研究和大量的实践,终于发现,通过对现有无导线起搏器的结构进行改进,能够使得所述无导线起搏器具有射频功能。Due to the long-term commitment to the research and development of wireless pacemakers, the inventors of the present invention have finally found through continuous in-depth research and a lot of practice that by improving the structure of the existing leadless pacemakers, the described Leadless pacemakers have radiofrequency capabilities.
为了实现上述思想,本发明提供了无导线起搏器、输送装置及系统,所述无导线起搏器包括第一壳体、第二壳体、设置在第一壳体内的第一单元、以及设置在第二壳体内的第二单元和起搏器本体;所述第二单元与所述起搏器本体和所述第一单元电连接。本发明提出的无导线起搏器具有高数据传输率,通信距离远的优点,能够提高患者植入无导线起搏器后随访的便捷性。以下对本发明提出的一种无导线起搏器作详细说明。In order to realize the above ideas, the present invention provides a leadless pacemaker, a delivery device and a system. The leadless pacemaker includes a first housing, a second housing, a first unit disposed in the first housing, and The second unit and the pacemaker body are arranged in the second casing; the second unit is electrically connected with the pacemaker body and the first unit. The leadless pacemaker proposed by the present invention has the advantages of high data transmission rate and long communication distance, and can improve the convenience of follow-up visits after patients are implanted with the leadless pacemaker. A leadless pacemaker proposed by the present invention will be described in detail below.
本发明的其中一个实施例提供了一种无导线起搏器。参见图2,图2为本实施例提供的无导线起搏器的结构示意图。从图2可以看出,本实施例提供的无导线起搏器,包括第一壳体110、第二壳体120、设置在第一壳体110内的第一单元200、以及设置在第二壳体120内的第二单元300和起搏器本体 400;所述第二单元300与所述起搏器本体400和所述第一单元200电连接。One embodiment of the present invention provides a leadless pacemaker. Referring to FIG. 2, FIG. 2 is a schematic structural diagram of the leadless pacemaker provided by this embodiment. It can be seen from FIG. 2 that the leadless pacemaker provided by this embodiment includes a first housing 110, a second housing 120, a first unit 200 disposed in the first housing 110, and a first unit 200 disposed in the second The second unit 300 and the pacemaker body 400 inside the casing 120 ; the second unit 300 is electrically connected with the pacemaker body 400 and the first unit 200 .
具体地,所述第一单元200,其被配置为接收体外控制装置的控制信息;所述第二单元300,其被配置为接收所述控制信息,并用于将所述控制信息发送至所述起搏器本体400;所述起搏器本体400,其被配置为根据所述控制信息,控制所述无导线起搏器的运行;并将所述无导线起搏器的运行信息发送至所述第二单元300;所述第二单元300,还被配置为将所述运行信息发送至所述第一单元200,所述第一单元200还被配置为将所述运行信息发送至所述体外控制装置。Specifically, the first unit 200 is configured to receive control information of an in vitro control device; the second unit 300 is configured to receive the control information and send the control information to the Pacemaker body 400; the pacemaker body 400 is configured to control the operation of the leadless pacemaker according to the control information; and send the operation information of the leadless pacemaker to the The second unit 300; the second unit 300 is also configured to send the operation information to the first unit 200, and the first unit 200 is also configured to send the operation information to the External control device.
其中,所述第一壳体110由生物可兼容非金属材料制成;所述第二壳体120包括由生物可兼容金属材料制成的封闭壳体。其中,所述生物可兼容非金属材料包括但不限于生物玻璃、生物陶瓷、生物水泥及生物玻璃陶瓷等。如此配置,所述第一壳体110不仅能够保证所述第一单元200与外部保持绝缘状态,进一步地,所述生物可兼容非金属材料易于高温消毒,且在人体内化学稳定性好、组织相容性好,抗压强度高;再进一步地,所述第一壳体110能够避免将所述第一单元200与植入受体的血液和/或器官组织直接接触,避免了所述第一单元200免受植入受体血液和/或器官组织的影响和侵蚀。更进一步地,所述第一壳体110能够与外部输送装置(例如输送手柄)配合工作,以将该所述无导线起搏器输入至目标位置;将所述第一单元200设置在所述第一壳体110内,可以在确保信号稳定传输的情况下,不增加所述导线起搏器的整体体积,有效利用可利用空间。所述生物可兼容金属材料制成包括但不限于钛、钽、铌和锆等纯金属、医用不锈钢、钴基合金、钛基合金等合金。如此配置,所述第二壳体120的耐蚀性能好,能够使得所述第二单元300和起搏器本体400不受外部的影响而失去功能,延长其使用寿命。Wherein, the first casing 110 is made of biocompatible non-metallic material; the second casing 120 includes a closed casing made of biocompatible metal material. Wherein, the biocompatible non-metallic materials include but not limited to bioglass, bioceramics, biocement, and bioglass ceramics. With such a configuration, the first housing 110 can not only ensure that the first unit 200 remains insulated from the outside, but also, the biocompatible non-metallic material is easy to be sterilized at high temperature, and has good chemical stability in the human body, tissue Good compatibility and high compressive strength; further, the first housing 110 can avoid direct contact between the first unit 200 and the blood and/or organ tissue of the implanted recipient, avoiding the first A unit 200 is protected from impact and erosion by blood and/or organ tissue of the implanted recipient. Furthermore, the first housing 110 can cooperate with an external delivery device (such as a delivery handle) to deliver the leadless pacemaker to a target position; the first unit 200 is set on the In the first casing 110 , under the condition of ensuring stable signal transmission, the overall volume of the lead pacemaker is not increased, and the available space can be effectively used. The biocompatible metal materials include but are not limited to pure metals such as titanium, tantalum, niobium and zirconium, medical stainless steel, cobalt-based alloys, titanium-based alloys and other alloys. With such a configuration, the second casing 120 has good corrosion resistance, which can prevent the second unit 300 and the pacemaker body 400 from losing their functions due to external influences and prolong their service life.
由此可见,本发明提供的无导线起搏器的第一单元200包括但不限于能够接收和发送射频信号的天线,所述第一单元200单独位于第一壳体110内,保证发送或接收的射频信号不会被衰减屏蔽,能够实现无导线起搏器与体外控制装置之间的远距离数据交互;进一步地,所述第二单元300和起搏器本体400位于所述第二壳体120内,所述第二壳体120能够避免所述第二单元 300和所述起搏器本体400受植入受体血液和/或器官组织的影响和侵蚀,同时也降低了所述第二单元300和所述起搏器本体400对植入受体器官组织的损伤。由此,本发明提供的无导线起搏器能够使得射频信号不受金属外壳的屏蔽衰减作用,实现无导线起搏器的射频通信功能。It can be seen that the first unit 200 of the leadless pacemaker provided by the present invention includes, but is not limited to, an antenna capable of receiving and transmitting radio frequency signals. The radio frequency signal will not be attenuated and shielded, and the remote data interaction between the leadless pacemaker and the external control device can be realized; further, the second unit 300 and the pacemaker body 400 are located in the second housing 120, the second housing 120 can prevent the second unit 300 and the pacemaker body 400 from being affected and eroded by the blood and/or organ tissue of the implanted recipient, and also reduce the second The damage of the unit 300 and the pacemaker body 400 to the organ tissue of the implanted recipient. Therefore, the leadless pacemaker provided by the present invention can prevent the radio frequency signal from being shielded and attenuated by the metal casing, and realize the radio frequency communication function of the leadless pacemaker.
综上,本发明提供的无导线起搏器具有高数据传输率,通信距离远的优点,能够提高患者植入无导线起搏器后随访的便捷性。To sum up, the leadless pacemaker provided by the present invention has the advantages of high data transmission rate and long communication distance, and can improve the convenience of follow-up visits after the implantation of the leadless pacemaker.
较佳地,在其中一种实施方式中,参见图3,图3为第二单元的其中一种结构示意图。从图3可以看出,所述第二单元300包括匹配网络模块310,以及与所述匹配网络模块310电连接的射频信号接收模块320和射频信号发送模块330。Preferably, in one implementation manner, refer to FIG. 3 , which is a schematic structural diagram of the second unit. It can be seen from FIG. 3 that the second unit 300 includes a matching network module 310 , and a radio frequency signal receiving module 320 and a radio frequency signal sending module 330 electrically connected to the matching network module 310 .
具体地,所述射频信号接收模块320,其被配置为将所述控制信息从射频信号转化为低频信号;所述射频信号发送模块330,其被配置为将所述运行信息从低频信号转化为射频信号。其中,所述第二单元300与所述起搏器本体400和所述第一单元200电连接,包括:所述射频信号接收模块320和所述射频信号发送模块330均与所述起搏器本体400电连接;所述匹配网络模块310与所述第一单元200电连接。Specifically, the radio frequency signal receiving module 320 is configured to convert the control information from radio frequency signals into low frequency signals; the radio frequency signal sending module 330 is configured to convert the operating information from low frequency signals to RF signal. Wherein, the second unit 300 is electrically connected to the pacemaker body 400 and the first unit 200, including: the radio frequency signal receiving module 320 and the radio frequency signal sending module 330 are both connected to the pacemaker The main body 400 is electrically connected; the matching network module 310 is electrically connected to the first unit 200 .
本领域的技术人员可以理解地,所述匹配网络模块310用于使得所述第二单元300和体外控制装置的电气特性相一致形成RF匹配网路,以使得无线电信号传输的损耗和失真最小。所述电气特性相一致也称为阻抗匹配,包括信号源(体外控制装置)的内阻与所接传输线的特性阻抗大小相等且相位相同,和/或传输线的特性阻抗与所接负载(第二单元)的阻抗的大小相等且相位相同。进一步地,所述射频信号接收模块320和所述射频信号发送模块330仅是较佳实施方式的示例性描述,而非本发明的限制,在其他的实施方式中,所述射频信号接收模块320和所述射频信号发送模块330也可以为一体式的射频信号收发模块,本发明对此不作限制。Those skilled in the art can understand that the matching network module 310 is used to make the electrical characteristics of the second unit 300 and the external control device consistent to form an RF matching network, so as to minimize the loss and distortion of radio signal transmission. The same electrical characteristics are also called impedance matching, including that the internal resistance of the signal source (external control device) is equal in size and phase to the characteristic impedance of the connected transmission line, and/or the characteristic impedance of the transmission line is the same as the connected load (second unit) impedances are equal in magnitude and in phase. Further, the radio frequency signal receiving module 320 and the radio frequency signal sending module 330 are only exemplary descriptions of preferred embodiments, rather than limitations of the present invention. In other embodiments, the radio frequency signal receiving module 320 The RF signal transmitting module 330 may also be an integrated RF signal transmitting and receiving module, which is not limited in the present invention.
较佳地,在其中一种实施方式中,参见图2,从图2可以看出,本实施例提供的无导线起搏器还包括第一信号传输单元500,所述第一信号传输单元500的一端位于所述第一壳体110内,所述第一信号传输单元500的另一端位 于所述第二壳体120内。所述第一单元200连接所述第一信号传输单元500的一端,所述匹配网络模块310连接所述第一信号传输单元500的另一端。如此配置,所述第一信号传输单元500能够保证所述第一单元200和所述第二单元300之间的电信号畅通,具体地,所述第一信号传输单元500为一馈通元件。Preferably, in one of the implementation manners, referring to FIG. 2, it can be seen from FIG. 2 that the leadless pacemaker provided in this embodiment further includes a first signal transmission unit 500, and the first signal transmission unit 500 One end of the first signal transmission unit 500 is located in the first housing 110 , and the other end of the first signal transmission unit 500 is located in the second housing 120 . The first unit 200 is connected to one end of the first signal transmission unit 500 , and the matching network module 310 is connected to the other end of the first signal transmission unit 500 . With such a configuration, the first signal transmission unit 500 can ensure smooth electrical signals between the first unit 200 and the second unit 300, specifically, the first signal transmission unit 500 is a feed-through element.
较佳地,在其中一种实施方式中,本发明提供的所述无导线起搏器还包括与所述起搏器本体400电连接的第二信号传输单元600,所述第二信号传输单元600的一端位于所述第二壳体120内,所述第二信号传输单元600的另一端位于所述第二壳体120外。具体地,所述第二信号传输单元600,其被配置为将受体的生理信息发送至所述起搏器本体400。如此配置,作为所述第二壳体120的内部电路组件与外部电路(图中未示出,设置在所述无导线起博器的前端,所述外部电路包括但不限于生理参数传感器、起搏传感器)连接的通道,能够使得所述第二壳体120内部的起搏器本体能够与外部电路进行电信号传递,使得所述起搏器本体400能够感知和/或起搏所述植入受体,具体地,所述第二信号传输单元600为一馈通元件。Preferably, in one of the implementation manners, the leadless pacemaker provided by the present invention further includes a second signal transmission unit 600 electrically connected to the pacemaker body 400, and the second signal transmission unit One end of the 600 is located inside the second housing 120 , and the other end of the second signal transmission unit 600 is located outside the second housing 120 . Specifically, the second signal transmission unit 600 is configured to transmit the physiological information of the subject to the pacemaker body 400 . So configured, as the internal circuit components and external circuits of the second housing 120 (not shown in the figure, they are arranged at the front end of the leadless pacemaker, the external circuits include but not limited to physiological parameter sensors, pacemaker pacing sensor) can enable the pacemaker body inside the second housing 120 to transmit electrical signals with external circuits, so that the pacemaker body 400 can sense and/or pace the implanted The receiver, specifically, the second signal transmission unit 600 is a feedthrough element.
较佳地,在其中一种实施方式中,还包括第三壳体130,所述第三壳体130由生物可兼容非金属材料制成。所述第二信号传输单元600位于所述第二壳体120外的另一端延伸入所述第三壳体130内。如此配置,所述第三壳体130不仅能够保护所述第二信号传输单元600,使得所述无导线起搏器能够满足增加和植入受体(比如心肌)的接触紧密度的要求;而且在其中一种较佳实施方式中,所述第三壳体130也能够作为固定单元700的基座。具体地,如前所述,所述生物可兼容非金属材料包括但不限于生物玻璃、生物陶瓷、生物水泥及生物玻璃陶瓷等,在此不再赘述。Preferably, in one of the implementation manners, a third housing 130 is further included, and the third housing 130 is made of biocompatible non-metallic material. The other end of the second signal transmission unit 600 outside the second housing 120 extends into the third housing 130 . With such a configuration, the third housing 130 can not only protect the second signal transmission unit 600, so that the leadless pacemaker can meet the requirements of increased contact tightness with implanted recipients (such as myocardium); and In one of the preferred implementation manners, the third housing 130 can also serve as the base of the fixing unit 700 . Specifically, as mentioned above, the biocompatible non-metallic materials include but are not limited to bioglass, bioceramics, biocement, and bioglass ceramics, etc., which will not be repeated here.
优选地,作为一种优选实施方式,继续参见图2,沿所述无导线起搏器的长度方向,所述第一壳体110、所述第二壳体120和所述第三壳体130的中心线位于同一直线上。较佳地,所述第一壳体110和所述第二壳体120的连接处为密闭连接,即所述第一信号传输单元500完全被所述第一壳体110和所述第二壳体120所密闭覆裹;同样地,所述第二壳体120和所述第三壳体130 的连接处也为密闭连接,即所述第二信号传输单元600完全被所述第二壳体120和所述第三壳体130所密闭覆裹。如此配置,能够避免所述第一信号传输单元500和所述第二信号传输单元600受外界的干扰,从而保证信号传输质量。进一步地,所述第一壳体110、所述第二壳体120和所述第三壳体130均为圆柱体,外径相同,如此配置,使得所述无导线起搏器的外形类似胶囊结构,不仅便于传输装置的运输和植入,而且大大减少了其外部尺寸,减少与植入受体的接触面积,能够精准接近病灶,从而提高治疗效果。Preferably, as a preferred embodiment, continue to refer to FIG. 2 , along the length direction of the leadless pacemaker, the first casing 110 , the second casing 120 and the third casing 130 centerlines are on the same straight line. Preferably, the connection between the first housing 110 and the second housing 120 is a hermetic connection, that is, the first signal transmission unit 500 is completely enclosed by the first housing 110 and the second housing. Body 120 is airtightly covered; similarly, the connection between the second housing 120 and the third housing 130 is also airtight connection, that is, the second signal transmission unit 600 is completely covered by the second housing 120 and the third casing 130 are airtightly covered. Such a configuration can prevent the first signal transmission unit 500 and the second signal transmission unit 600 from being interfered by the outside world, thereby ensuring signal transmission quality. Further, the first casing 110, the second casing 120 and the third casing 130 are all cylinders with the same outer diameter, and are configured in such a way that the shape of the leadless pacemaker is similar to a capsule The structure not only facilitates the transportation and implantation of the transmission device, but also greatly reduces its external size, reduces the contact area with the implanted receptor, and can accurately approach the lesion, thereby improving the therapeutic effect.
较佳地,在其中一种实施方式中,继续参见图2,所述无导线起搏器还包括一固定单元700,所述固定单元700的一端固定在所述第三壳体130的外壁,并且所述固定单元700的另一端用于固定在所述受体上。如此配置,所述固定单元700能够将无导线起搏器固定到植入受体(比如心肌)上,使得所述无导线起搏器的前端能够和心肌紧密接触。进一步地,所述第三壳体130作为固定单元700的基座,更便于将所述固定单元700与所述无导线起搏器紧密固定在一起。Preferably, in one of the implementation manners, referring to FIG. 2 , the leadless pacemaker further includes a fixing unit 700, one end of the fixing unit 700 is fixed on the outer wall of the third housing 130, And the other end of the fixing unit 700 is used to be fixed on the receptor. Configured in this way, the fixing unit 700 can fix the leadless pacemaker to the implant recipient (such as the myocardium), so that the front end of the leadless pacemaker can be in close contact with the myocardium. Further, the third housing 130 serves as the base of the fixing unit 700, which is more convenient for tightly fixing the fixing unit 700 and the leadless pacemaker together.
较佳地,在其中一种实施方式中,所述无导线起搏器还包括与所述起搏器本体400电连接的电池单元800,所述电池单元800设置在所述第二壳体120内,所述电池单元800用于为所述起搏器本体400和/或所述第二单元300供电。进一步地,所述第二信号传输单元600和所述电池单元800分别位于所述起搏器本体400相对的两端。如此配置,使得所述无导线起搏器各个功能组件之间更加紧凑合理,进一步减少了所述无导线起搏器的外部尺寸。Preferably, in one of the implementation manners, the leadless pacemaker further includes a battery unit 800 electrically connected to the pacemaker body 400 , and the battery unit 800 is arranged in the second casing 120 Inside, the battery unit 800 is used for powering the pacemaker body 400 and/or the second unit 300 . Further, the second signal transmission unit 600 and the battery unit 800 are respectively located at opposite ends of the pacemaker body 400 . Such a configuration makes the various functional components of the leadless pacemaker more compact and reasonable, and further reduces the external size of the leadless pacemaker.
较佳地,在其中一种实施方式中,参见图4,图4为本发明提供的无导线起搏器的其中一种电池单元示意图。结合图2和图4可以看出,所述电池单元800位于所述无导线起搏器本体400和所述第二单元300之间,且所述电池单元800的外壁具有一凹槽;连接所述起搏器本体400和所述第二单元300的信号线位于所述凹槽内。与传统的电池为圆柱体不同,本实施例的电池单元800具有一凹槽,如此配置,进一步使得所述第二单元300和所述起搏器本体400之间的信号线充分利用空间,不仅布线合理易于实施,而且合理利用空间,减少了所述无导线起搏器的体积。Preferably, in one of the implementation manners, see FIG. 4 , which is a schematic diagram of one battery unit of the leadless pacemaker provided by the present invention. 2 and 4, it can be seen that the battery unit 800 is located between the leadless pacemaker body 400 and the second unit 300, and the outer wall of the battery unit 800 has a groove; The signal lines of the pacemaker body 400 and the second unit 300 are located in the groove. Different from the traditional cylindrical battery, the battery unit 800 of this embodiment has a groove. Such configuration further enables the signal line between the second unit 300 and the pacemaker body 400 to make full use of the space, not only The wiring is reasonable and easy to implement, and the space is rationally utilized to reduce the volume of the leadless pacemaker.
在其中一种示范性实施方式中,所述无导线起搏器为心脏无导线起搏器,植入受体包括患者的心腔。参见图5,图5为所述无导线起搏器的所述起搏器本体的其中一种结构示意图。从图5可以看出,所述起搏器本体400包括:数据处理单元410、以及与所述数据处理单元410电连接的腔内心电感知处理模块420、心肌接触评估模块430和起搏电压产生模块440。In one of the exemplary embodiments, the leadless pacemaker is a cardiac leadless pacemaker, and the implanted recipient includes a cardiac chamber of a patient. Referring to FIG. 5 , FIG. 5 is a structural schematic diagram of the pacemaker body of the leadless pacemaker. It can be seen from FIG. 5 that the pacemaker body 400 includes: a data processing unit 410, an intracavity electrocardiographic sensing processing module 420 electrically connected to the data processing unit 410, a myocardial contact evaluation module 430, and a pacing voltage generating module. Module 440.
具体地,所述腔内心电感知处理模块420,其被配置为对患者的心电活动进行检测,并根据所述患者的心电活动信息获取患者的生理信息。所述心肌接触评估模块430,其被配置为监测无导线起搏器和心肌的接触状态,并获取所述无导线起搏器的植入状态信息。所述数据处理单元410,其被配置为根据所述控制信息、所述生理信息和所述植入状态信息,产生起搏控制。所述起搏电压产生模块440,其被配置为根据所述起搏控制,产生脉冲刺激电压;所述脉冲刺激电压经由所述第二信号传输单元600发送至所述第二壳体120外。Specifically, the intracavity electrocardiographic sensing processing module 420 is configured to detect the patient's electrocardiographic activity, and obtain the patient's physiological information according to the patient's electrocardiographic activity information. The myocardial contact evaluation module 430 is configured to monitor the contact state between the leadless pacemaker and the myocardium, and obtain information about the implantation state of the leadless pacemaker. The data processing unit 410 is configured to generate pacing control according to the control information, the physiological information and the implantation status information. The pacing voltage generation module 440 is configured to generate a pulse stimulation voltage according to the pacing control; the pulse stimulation voltage is sent out of the second casing 120 through the second signal transmission unit 600 .
其中,所述第二单元300与所述起搏器本体400电连接,包括:所述起搏器本体400的所述数据处理单元410与所述第二单元300连接。进一步地,所述起搏器本体400与所述第二信号传输单元600电连接,包括所述腔内心电感知处理模块420和所述起搏电压产生模块440与所述第二信号传输单元600电连接。Wherein, the second unit 300 is electrically connected to the pacemaker body 400 , including: the data processing unit 410 of the pacemaker body 400 is connected to the second unit 300 . Further, the pacemaker body 400 is electrically connected to the second signal transmission unit 600, including the intracavity electrocardiographic sensing processing module 420 and the pacing voltage generation module 440 and the second signal transmission unit 600 electrical connection.
较佳地,在其中一种实施方式中,所述运行信息包括所述受体的生理信息和所述无导线起博器的植入状态信息。具体地,所述起搏器本体400用于,将所述生理信息和所述植入状态信息发送至所述第二单元300。进一步地,所述第二单元300经由所述第一单元200将所述生理信息和所述植入状态信息发送给体外控制装置。如此配置,能够使得体外控制装置及时获悉所述无导线起搏器的实时工作状态及患者的生理状态,从而调节所述控制信息,以使得所述无导线起搏器能够适应患者的生理变化,更加安全有效地进行起搏刺激。Preferably, in one of the implementation manners, the operation information includes physiological information of the recipient and implantation status information of the leadless pacemaker. Specifically, the pacemaker body 400 is configured to send the physiological information and the implantation status information to the second unit 300 . Further, the second unit 300 sends the physiological information and the implantation status information to an in vitro control device via the first unit 200 . With such a configuration, the external control device can be informed of the real-time working state of the leadless pacemaker and the physiological state of the patient in time, so as to adjust the control information so that the leadless pacemaker can adapt to the physiological changes of the patient, Safer and more effective pacing stimulation.
较佳地,在其中一种实施方式中,所述运行信息还包括电池信息。所述起搏器本体还包括电池性能检测模块450,所述电池性能检测模块450,被配置为监测电池运行状态,并根据所述电池运行状态获取所述电池信息,并将 所述电池信息发送至起搏器本体(在该实施例中,为所述数据处理单元410)。如此配置,在电池电量耗尽前做出告警信息,以便及时作相应的处理。显然地,在其他的实施方式中,所述电池信息还包括电池的寿命、健康状态等,不再一一赘述。Preferably, in one of the implementation manners, the running information also includes battery information. The pacemaker body also includes a battery performance detection module 450, the battery performance detection module 450 is configured to monitor the battery operating state, obtain the battery information according to the battery operating state, and send the battery information to to the pacemaker body (in this embodiment, the data processing unit 410). With such a configuration, an alarm message will be issued before the battery power is exhausted, so as to deal with it in time. Obviously, in other implementation manners, the battery information also includes battery life, health status, etc., which will not be repeated here.
具体地,所述起搏器本体400,还被配置为将所述电池信息发送至所述第二单元300。进一步地,所述第二单元300经由所述第一单元200将所述电池信息发送给体外控制装置。如此配置,能够使得体外控制装置及时获悉所述无导线起搏器的电池健康状态,从而及时采取相应的应对措施,以使得所述无导线起搏器能够正常运行。Specifically, the pacemaker body 400 is further configured to send the battery information to the second unit 300 . Further, the second unit 300 sends the battery information to the external control device via the first unit 200 . With such a configuration, the external control device can be informed of the battery health status of the leadless pacemaker in time, so that corresponding countermeasures can be taken in time, so that the leadless pacemaker can operate normally.
综上,本发明提供的无导线起搏器,所述第一单元200位于第一壳体110内,保证发送或接收的射频信号不会被第二壳体120衰减屏蔽,实现了无导线起搏器与体外控制装置之间进行远距离数据交互;进一步地,所述第二单元300和起搏器本体400位于所述第二壳体120内,能够避免所述第二单元300和所述起搏器本体400免受植入受体生理影响和侵蚀,同时也降低了所述第二单元300和起搏器本体400对植入受体器官组织的损伤。由此,本发明提供的无导线起搏器具有高数据传输率,通信距离远的优点,能够提高患者植入无导线起搏器后随访的便捷性。To sum up, in the leadless pacemaker provided by the present invention, the first unit 200 is located in the first casing 110 to ensure that the transmitted or received radio frequency signal will not be attenuated and shielded by the second casing 120, realizing the leadless pacemaker. Remote data exchange between the pacemaker and the external control device; further, the second unit 300 and the pacemaker body 400 are located in the second housing 120, which can avoid the second unit 300 and the pacemaker The pacemaker body 400 is protected from the physiological impact and erosion of the implant recipient, and at the same time reduces the damage of the second unit 300 and the pacemaker body 400 to the organ tissue of the implant recipient. Therefore, the leadless pacemaker provided by the present invention has the advantages of high data transmission rate and long communication distance, and can improve the convenience of follow-up visits after the implantation of the leadless pacemaker.
本发明的又一实施方式还提供了一种输送装置,所述输送装置用于输送上述任一实施方式所述的无导线起搏器。具体地,参见图6,图6为本发明一实施例提供的传输装置结构示意图。从图6可以看出,所述输送装置包括:输送手柄组件930、输送杆组件920和与所述无导线起搏器的所述第一壳体110配合的头端部件910,所述头端部件910设置在所述输送杆组件920的远端,所述输送手柄组件930设置在所述输送杆组件920的近端并经所述输送杆组件920与所述头端部件910相连;所述输送装置被配置为将所述无导线起搏器推送至目标位置,并在到达所述目标位置后,释放所述无导线起搏器。Another embodiment of the present invention also provides a delivery device, which is used for delivering the leadless pacemaker described in any one of the above-mentioned embodiments. Specifically, referring to FIG. 6, FIG. 6 is a schematic structural diagram of a transmission device provided by an embodiment of the present invention. It can be seen from FIG. 6 that the delivery device includes: a delivery handle assembly 930, a delivery rod assembly 920, and a head end part 910 that cooperates with the first housing 110 of the leadless pacemaker. The component 910 is arranged at the far end of the delivery rod assembly 920, and the delivery handle assembly 930 is arranged at the proximal end of the delivery rod assembly 920 and connected to the head end part 910 through the delivery rod assembly 920; The delivery device is configured to advance the leadless pacemaker to a target location, and upon reaching the target location, release the leadless pacemaker.
综上,本发明提供的无导线起搏器能够使用图6所示的输送装置经股静脉植入到患者右心室心腔内。其中所述输送装置的头端部件910与所述无导线起搏器的所述第一壳体110连接后将无导线起搏器输入体内。显然地,现 有技术中能够起到如上作用的任何输送装置均可输送本发明提出的无导线起搏器,本发明对此不作任何限制;进一步地,本发明提出的所述无导线起搏器也不仅限于通过输送装置输送,也可采用其它方式安装,本发明对此同样不进行任何限定。In summary, the leadless pacemaker provided by the present invention can be implanted into the patient's right ventricle via the femoral vein using the delivery device shown in FIG. 6 . Wherein the head end part 910 of the delivery device is connected with the first casing 110 of the leadless pacemaker, and then the leadless pacemaker is delivered into the body. Obviously, any delivery device in the prior art that can play the above role can deliver the leadless pacemaker proposed by the present invention, and the present invention does not make any limitation thereto; further, the leadless pacemaker proposed by the present invention The device is not limited to be transported by the transport device, but can also be installed in other ways, which is not limited in the present invention.
本发明的又一实施方式还提供了一种无导线起搏系统,所述无导线起搏系统包括上述任一项所述的无导线起搏器以及上述的输送装置。Another embodiment of the present invention also provides a leadless pacing system, which includes the leadless pacemaker described in any one of the above and the above delivery device.
由于本发明提供的无导线起搏系统,与本发明提供的所述无导线起搏器属于同一发明构思,因此,至少具有与其相同的有益效果,在此,不再一一赘述。Since the leadless pacing system provided by the present invention belongs to the same inventive concept as the leadless pacemaker provided by the present invention, it has at least the same beneficial effect, which will not be repeated here.
本发明的再一实施方式提供了一种基于植入式医疗电子器件的无线通信系统,所述无线通信系统包括体内植入装置和体外控制装置;其中,所述体内植入装置包括上述任一实施方式所述的无导线起搏器,所述体外控制装置包括无线通信单元,该无线通信单元用于与所述无导线起搏器的第一单元通信连接。Another embodiment of the present invention provides a wireless communication system based on implantable medical electronic devices, the wireless communication system includes an internal implant device and an external control device; wherein the internal implant device includes any of the above-mentioned In the leadless pacemaker described in the embodiment, the external control device includes a wireless communication unit, and the wireless communication unit is used for communicating with the first unit of the leadless pacemaker.
综上,由于本发明提出的所述无导线起搏器具有设置在第一壳体110内的第一单元200、以及设置在第二壳体120内的第二单元300和起搏器本体400;所述第二单元300与所述起搏器本体400和所述第一单元200电连接。如此配置,具有本发明提出的无导线起搏器的无线通信系统,能够克服现有技术中近场耦合存在的载波频率低,数据传输率低,通信距离短以及人体通信存在的通信质量较差的缺陷,能够保证发送或接收的射频信号不会衰减屏蔽,从而实现了无导线起搏器与体外控制装置之间进行远距离的数据交互,提高了患者植入无导线起搏器后随访的便捷性。In summary, the leadless pacemaker proposed by the present invention has the first unit 200 disposed in the first housing 110 , the second unit 300 and the pacemaker body 400 disposed in the second housing 120 ; The second unit 300 is electrically connected to the pacemaker body 400 and the first unit 200 . With such a configuration, the wireless communication system with the leadless pacemaker proposed by the present invention can overcome the low carrier frequency, low data transmission rate, short communication distance and poor communication quality of human body communication in the prior art. It can ensure that the transmitted or received radio frequency signal will not be attenuated and shielded, thus realizing the long-distance data interaction between the leadless pacemaker and the external control device, and improving the follow-up safety of patients after implantation of the leadless pacemaker Convenience.
此外,术语“第一”、“第二”仅用于描述目的,而不能理解为指示或暗示相对重要性或者隐含指明所指示的技术特征的数量。由此,限定有“第一”、“第二”的特征可以明示或者隐含地包括至少一个该特征。在本发明的描述中,“多个”的含义是至少两个,例如两个,三个等,除非另有明确具体的限定。In addition, the terms "first" and "second" are used for descriptive purposes only, and cannot be interpreted as indicating or implying relative importance or implicitly specifying the quantity of indicated technical features. Thus, the features defined as "first" and "second" may explicitly or implicitly include at least one of these features. In the description of the present invention, "plurality" means at least two, such as two, three, etc., unless otherwise specifically defined.
在本说明书的描述中,参考术语“一个实施例”、“一些实施例”、“示例”、“具体示例”、或“一些示例”等的描述意指结合该实施例或示例描述的具体特 征、结构、材料或者特点包含于本发明的至少一个实施例或示例中。在本说明书中,对上述术语的示意性表述不必须针对的是相同的实施例或示例。而且,描述的具体特征、结构、材料或者特点可以在任一个或多个实施例或示例中以合适的方式结合。此外,在不相互矛盾的情况下,本领域的技术人员可以将本说明书中描述的不同实施例或示例以及不同实施例或示例的特征进行结合和组合。In the description of this specification, descriptions referring to the terms "one embodiment", "some embodiments", "example", "specific examples", or "some examples" mean that specific features described in connection with the embodiment or example , structure, material or characteristic is included in at least one embodiment or example of the present invention. In this specification, the schematic representations of the above terms are not necessarily directed to the same embodiment or example. Furthermore, the described specific features, structures, materials or characteristics may be combined in any suitable manner in any one or more embodiments or examples. In addition, those skilled in the art can combine and combine different embodiments or examples and features of different embodiments or examples described in this specification without conflicting with each other.
综上,上述实施例对无导线起搏器、输送装置及系统的不同构型进行了详细说明,当然,上述描述仅是对本发明较佳实施例的描述,并非对本发明范围的任何限定,本发明包括但不局限于上述实施中所列举的构型,本领域技术人员可以根据上述实施例的内容举一反三,本发明领域的普通技术人员根据上述揭示内容做的任何变更、修饰,均属于权利要求书的保护范围。To sum up, the above-mentioned embodiments have described in detail the different configurations of the leadless pacemaker, the delivery device and the system. Of course, the above-mentioned description is only a description of the preferred embodiments of the present invention, and is not intended to limit the scope of the present invention. The invention includes but is not limited to the configurations listed in the above implementation. Those skilled in the art can draw inferences based on the content of the above embodiments. Any changes and modifications made by those of ordinary skill in the field of the invention based on the above disclosures belong to the claims. protection scope of the book.

Claims (13)

  1. 一种无导线起搏器,其特征在于,包括第一壳体、第二壳体、设置在第一壳体内的第一单元以及设置在第二壳体内的第二单元和起搏器本体;所述第二单元分别与所述起搏器本体和所述第一单元电连接;A leadless pacemaker, characterized by comprising a first housing, a second housing, a first unit disposed in the first housing, a second unit disposed in the second housing, and a pacemaker body; The second unit is electrically connected to the pacemaker body and the first unit respectively;
    所述第一单元,其被配置为接收体外控制装置的控制信息;The first unit is configured to receive control information from an in vitro control device;
    所述第二单元,其被配置为接收所述控制信息,并用于将所述控制信息发送至所述起搏器本体;The second unit is configured to receive the control information and send the control information to the pacemaker body;
    所述起搏器本体,其被配置为根据所述控制信息,控制所述无导线起搏器的运行,并将所述无导线起搏器的运行信息发送至所述第二单元;The pacemaker body is configured to control the operation of the leadless pacemaker according to the control information, and send the operation information of the leadless pacemaker to the second unit;
    所述第二单元,还被配置为将所述运行信息发送至所述第一单元,所述第一单元还被配置为将所述运行信息发送至所述体外控制装置;The second unit is further configured to send the operation information to the first unit, and the first unit is further configured to send the operation information to the in vitro control device;
    其中,所述第一壳体由生物可兼容非金属材料制成;所述第二壳体包括由生物可兼容金属材料制成的封闭壳体。Wherein, the first casing is made of biocompatible non-metallic material; the second casing includes a closed casing made of biocompatible metal material.
  2. 根据权利要求1所述的无导线起搏器,其特征在于,还包括第一信号传输单元,所述第一信号传输单元的第一端位于所述第一壳体内,所述第一信号传输单元的第二端位于所述第二壳体内;The leadless pacemaker according to claim 1, further comprising a first signal transmission unit, the first end of the first signal transmission unit is located in the first housing, and the first signal transmission the second end of the unit is located within the second housing;
    所述第一单元连接所述第一信号传输单元的第一端,所述第二单元连接所述第一信号传输单元的第二端。The first unit is connected to the first end of the first signal transmission unit, and the second unit is connected to the second end of the first signal transmission unit.
  3. 根据权利要求1所述的无导线起搏器,其特征在于,还包括与所述起搏器本体电连接的第二信号传输单元,所述第二信号传输单元的第一端位于所述第二壳体内,所述第二信号传输单元的第二端位于所述第二壳体外;The leadless pacemaker according to claim 1, further comprising a second signal transmission unit electrically connected to the pacemaker body, the first end of the second signal transmission unit is located at the first Inside the second housing, the second end of the second signal transmission unit is located outside the second housing;
    所述第二信号传输单元,其被配置为将受体的生理信息发送至所述起搏器本体。The second signal transmission unit is configured to transmit the physiological information of the subject to the pacemaker body.
  4. 根据权利要求3所述的无导线起搏器,其特征在于,还包括第三壳体,所述第三壳体由生物可兼容非金属材料制成;The leadless pacemaker according to claim 3, further comprising a third casing, the third casing is made of biocompatible non-metallic material;
    所述第二信号传输单元的位于所述第二壳体外的第二端延伸入所述第三壳体内。The second end of the second signal transmission unit outside the second housing extends into the third housing.
  5. 根据权利要求4所述的无导线起搏器,其特征在于,还包括一固定单 元,所述固定单元的第一端固定在所述第三壳体的外壁,并且第二端用于固定在所述受体上。The leadless pacemaker according to claim 4, further comprising a fixing unit, the first end of the fixing unit is fixed on the outer wall of the third housing, and the second end is used to be fixed on on the receptor.
  6. 根据权利要求3所述的无导线起搏器,其特征在于,还包括与所述起搏器本体电连接的电池单元,所述电池单元设置在所述第二壳体内,所述电池单元用于为所述起搏器本体和/或所述第二单元供电。The leadless pacemaker according to claim 3, further comprising a battery unit electrically connected to the pacemaker body, the battery unit is arranged in the second casing, and the battery unit is used for for supplying power to the pacemaker body and/or the second unit.
  7. 根据权利要求6所述的无导线起搏器,其特征在于,所述第二信号传输单元和所述电池单元分别位于所述起搏器本体相对的两端。The leadless pacemaker according to claim 6, wherein the second signal transmission unit and the battery unit are located at two opposite ends of the pacemaker body.
  8. 根据权利要求6所述的无导线起搏器,其特征在于,所述电池单元位于所述起搏器本体和所述第二单元之间,且所述电池单元的外壁具有一凹槽;The leadless pacemaker according to claim 6, wherein the battery unit is located between the pacemaker body and the second unit, and the outer wall of the battery unit has a groove;
    连接所述起搏器本体和所述第二单元的信号线位于所述凹槽内。The signal line connecting the pacemaker body and the second unit is located in the groove.
  9. 根据权利要求1所述的无导线起搏器,其特征在于,所述运行信息包括受体的生理信息和所述无导线起搏器的植入状态信息;The leadless pacemaker according to claim 1, wherein the operating information includes physiological information of the recipient and implantation status information of the leadless pacemaker;
    所述起搏器本体用于将所述生理信息和所述植入状态信息发送至所述第二单元。The pacemaker body is used to send the physiological information and the implantation status information to the second unit.
  10. 根据权利要求1所述的无导线起搏器,其特征在于,所述运行信息还包括电池信息;The leadless pacemaker according to claim 1, wherein the running information further includes battery information;
    所述起搏器本体还包括电池性能检测模块,所述电池性能检测模块被配置为监测电池运行状态,并根据所述电池运行状态获取所述电池信息,并将所述电池信息发送至所述第二单元。The pacemaker body also includes a battery performance detection module, the battery performance detection module is configured to monitor the operating state of the battery, obtain the battery information according to the operating state of the battery, and send the battery information to the Second unit.
  11. 一种输送装置,其特征在于,所述输送装置用于输送如权利要求1~10任一项所述的无导线起搏器;A delivery device, characterized in that the delivery device is used to deliver the leadless pacemaker according to any one of claims 1-10;
    所述输送装置包括:输送手柄组件、输送杆组件和与所述无导线起搏器的所述第一壳体配合的头端部件,所述头端部件设置在所述输送杆组件的远端,所述输送手柄组件设置在所述输送杆组件的近端并经所述输送杆组件与所述头端部件相连;The delivery device includes: a delivery handle assembly, a delivery rod assembly, and a head-end part matched with the first casing of the leadless pacemaker, and the head-end part is arranged at the distal end of the delivery rod assembly , the delivery handle assembly is arranged at the proximal end of the delivery rod assembly and connected to the head end part through the delivery rod assembly;
    所述输送装置被配置为将所述无导线起搏器推送至目标位置,并在到达所述目标位置后,释放所述无导线起搏器。The delivery device is configured to advance the leadless pacemaker to a target location and, upon reaching the target location, to release the leadless pacemaker.
  12. 一种无导线起搏系统,其包括如权利要求1~10任一项所述的无导线 起搏器以及如权利要求11所述的输送装置。A leadless pacing system, comprising the leadless pacemaker according to any one of claims 1-10 and the delivery device according to claim 11.
  13. 一种基于植入式医疗电子器件的无线通信系统,其特征在于,包括体内植入装置和体外控制装置;A wireless communication system based on an implantable medical electronic device, characterized in that it includes an internal implant device and an external control device;
    其中,所述体内植入装置包括上述权利要求1~10任一项所述的无导线起搏器,所述体外控制装置包括无线通信单元,该无线通信单元用于与所述无导线起搏器的第一单元通信连接。Wherein, the implanted device in the body includes the leadless pacemaker according to any one of claims 1 to 10, and the external control device includes a wireless communication unit for communicating with the leadless pacemaker. The first unit communication connection of the device.
PCT/CN2022/094835 2021-06-02 2022-05-25 Leadless pacemaker, delivery device, and system WO2022253060A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN202110614197.8A CN115430054A (en) 2021-06-02 2021-06-02 Leadless pacemaker, delivery device and system
CN202110614197.8 2021-06-02

Publications (1)

Publication Number Publication Date
WO2022253060A1 true WO2022253060A1 (en) 2022-12-08

Family

ID=84240343

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2022/094835 WO2022253060A1 (en) 2021-06-02 2022-05-25 Leadless pacemaker, delivery device, and system

Country Status (2)

Country Link
CN (1) CN115430054A (en)
WO (1) WO2022253060A1 (en)

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108079437A (en) * 2016-11-21 2018-05-29 创领心律管理医疗器械(上海)有限公司 Pacemaker and its fixing means and transport system
CN108434600A (en) * 2018-02-26 2018-08-24 郭成军 Chambers of the heart implant, pacemaker, implanted device and method for implantation
CN207838033U (en) * 2016-12-09 2018-09-11 复旦大学附属中山医院 A kind of no conducting wire pacemaker fixing device and without conducting wire pacemaker system
EP3815738A1 (en) * 2019-11-01 2021-05-05 BIOTRONIK SE & Co. KG Implantable medical device comprising an anchoring element
CN112843474A (en) * 2020-12-22 2021-05-28 居天医疗科技(深圳)有限公司 Implanted cardiac pacemaker

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108079437A (en) * 2016-11-21 2018-05-29 创领心律管理医疗器械(上海)有限公司 Pacemaker and its fixing means and transport system
CN207838033U (en) * 2016-12-09 2018-09-11 复旦大学附属中山医院 A kind of no conducting wire pacemaker fixing device and without conducting wire pacemaker system
CN108434600A (en) * 2018-02-26 2018-08-24 郭成军 Chambers of the heart implant, pacemaker, implanted device and method for implantation
EP3815738A1 (en) * 2019-11-01 2021-05-05 BIOTRONIK SE & Co. KG Implantable medical device comprising an anchoring element
CN112843474A (en) * 2020-12-22 2021-05-28 居天医疗科技(深圳)有限公司 Implanted cardiac pacemaker

Also Published As

Publication number Publication date
CN115430054A (en) 2022-12-06

Similar Documents

Publication Publication Date Title
US8204596B2 (en) Isolation connector for an intravascular implantable medical device
US7174212B1 (en) Implantable medical device having a casing providing high-speed telemetry
EP0798016B1 (en) Implantable stimulus system having stimulus generator with pressure sensor and common lead for transmitting stimulus pulses to a body location and pressure signals from the body location to the stimulus generator
EP1406692B1 (en) Subcutaneous sensing feedthrough/electrode assembly
US5387232A (en) Method and apparatus for esophageal pacing
US8055332B2 (en) Wireless ECG in implantable devices
US9002470B2 (en) Supply noise rejection in implantable medical devices
US20070208390A1 (en) Implantable wireless sound sensor
US20130274847A1 (en) MRI Compatible Leadless Cardiac Pacemaker
US20080103406A1 (en) Integrated system for managing patients with heart failure
JP2004535230A (en) Subcutaneous detection feedthrough / electrode assembly
US9008788B2 (en) Enablement and/or disablement of an exposure mode of an implantable medical device
US20070265668A1 (en) Fault tolerant sensors and methods for implementing fault tolerance in implantable medical devices
JP2002506700A (en) System for deriving relative physiological signals
WO2016038599A4 (en) Flexible rechargeable implantable subcutaneous medical device structure and method of assembly
WO2022253060A1 (en) Leadless pacemaker, delivery device, and system
US20230369749A1 (en) Antenna for implantable medical devices
JP2011512945A (en) Atrial defibrillation using an implantable defibrillation system
CN110636881B (en) Antenna for implantable medical device
US20210251488A1 (en) Hermetically sealed implantable medical device and method of formation
US20110208262A1 (en) Lead-carried proximal electrode for quadripolar transthoracic impedance monitoring
JP2008538990A (en) Electric contact for feedthrough / electrode assembly
CN116634926A (en) IMD housing containing a feedthrough formed using a dielectric material

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 22815106

Country of ref document: EP

Kind code of ref document: A1

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 22815106

Country of ref document: EP

Kind code of ref document: A1